Intravenous administration of a thrombolytic agent is the only realistic therapeutic approach in evolving myocardial infarction.

Suppr

超能文献

作者信息

Verstraete M

出版信息

Eur Heart J. 1985 Jul;6(7):586-93. doi: 10.1093/oxfordjournals.eurheartj.a061906.

DOI:10.1093/oxfordjournals.eurheartj.a061906

PMID:3930247

Abstract

摘要

相似文献

Intravenous administration of a thrombolytic agent is the only realistic therapeutic approach in evolving myocardial infarction.

Eur Heart J. 1985 Jul;6(7):586-93. doi: 10.1093/oxfordjournals.eurheartj.a061906.

Systemic versus intracoronary thrombolytic treatment in acute myocardial infarction.

Acta Cardiol. 1985;40(3):263-7.

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.

N Engl J Med. 1993 Sep 2;329(10):673-82. doi: 10.1056/NEJM199309023291001.

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.

N Engl J Med. 1993 Nov 25;329(22):1615-22. doi: 10.1056/NEJM199311253292204.

Thrombolytic therapy for myocardial infarction: a perspective of clinical trialists. The GUSTO Investigators.

Clin Cardiol. 1992 Mar;15(3):143-4. doi: 10.1002/clc.4960150303.

Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.

JAMA. 1996 Mar 13;275(10):777-82.

GUSTO (Global Utilization of Streptokinase and Tissue plasminogen activator in Occluded arteries): logic wins at last.

Eur Heart J. 1994 Jan;15(1):2-4. doi: 10.1093/oxfordjournals.eurheartj.a060374.

[Fibrinolytic treatment of acute myocardial infarct].

Fortschr Med. 1986 Aug 14;104(30):578-82.

Thrombolytic treatment in acute myocardial infarction.

Circulation. 1990 Sep;82(3 Suppl):II96-109.

Clinical trials and decisions for thrombolytic therapy in patients with acute myocardial infarction.

Clin Cardiol. 1990 May;13(5):307-8. doi: 10.1002/clc.4960130502.

引用本文的文献

A history of streptokinase use in acute myocardial infarction.

Tex Heart Inst J. 2007;34(3):318-27.

Coronary thrombolysis.

Br Heart J. 1987 Apr;57(4):301-5. doi: 10.1136/hrt.57.4.301.

Anisoylated plasminogen streptokinase activator complex versus placebo. A preliminary multicentre study of safety and early mortality in acute myocardial infarction.

Drugs. 1987;33 Suppl 3:261-7. doi: 10.2165/00003495-198700333-00048.

Intracoronary streptokinase versus intravenous anisoylated plasminogen streptokinase activator complex in the treatment of acute myocardial infarction.

Drugs. 1987;33 Suppl 3:179-82. doi: 10.2165/00003495-198700333-00030.

Achievement of coronary artery patency by use of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.

Drugs. 1987;33 Suppl 3:117-23. doi: 10.2165/00003495-198700333-00019.

Back to the future: so what will fibrinolytic therapy offer your patients with myocardial infarction?

Br Med J (Clin Res Ed). 1986 Apr 12;292(6526):973-8. doi: 10.1136/bmj.292.6526.973.

Thrombolysis. An approach still on the move.

Drugs. 1989 Feb;37(2):116-22. doi: 10.2165/00003495-198937020-00002.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验